Citation

91 FR 18472

Multiple canonical documents share this first-page citation.

GlaxoSmithKline; Withdrawal of Approval of a New Drug Application for Wellcovorin (Leucovorin Calcium) Tablets, EQ 5 mg Base and EQ 25 mg Base Friday, April 10, 2026 91 FR 18472
Center for Scientific Review; Notice of Closed Meetings Friday, April 10, 2026 91 FR 18472